Clinical trial
A Randomized, Double Blind, Placebo-Controlled, Parallel Group, Dose-Response Study of MR-107A-01 in The Treatment of Post-Surgical Dental Pain
NCT04571515 is registered in ClinicalTrials.gov with Mylan Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double Blind, Placebo-Controlled, Parallel Group, Dose-Response Study of MR-107A-01 in The Treatment of Post-Surgical Dental Pain
- Lead sponsor
- Mylan Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 29, 2020
- Completion date
- December 22, 2020
- Enrollment
- 114 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pain, pain, acute, postoperative pain